login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
UNIQURE NV (QURE) Stock News
USA
- NASDAQ:QURE -
NL0010696654
-
Common Stock
59.99
USD
-2.84 (-4.52%)
Last: 10/16/2025, 8:11:01 PM
60
USD
+0.01 (+0.02%)
After Hours:
10/16/2025, 8:11:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
QURE Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Benzinga
- Mentions:
ACI
CVX
DDS
AVGO
...
Cramer Warns On One Chip Stock, Says Broadcom Is The Better Bet
15 days ago - By: Benzinga
- Mentions:
VRTX
DHR
HUM
MDT
...
10 Health Care Stocks Whale Activity In Today's Session
17 days ago - By: uniQure Inc.
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
17 days ago - By: uniQure Inc.
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
22 days ago - By: Stocktwits
- Mentions:
SPY
QQQ
DIA
LAC
...
Lithium Americas, Alibaba, uniQure, IREN, Cidara: Stocks Making The Biggest Moves Today
22 days ago - By: Investor's Business Daily
A Cure For Huntington's Disease? UniQure Launches More Than 240%.
21 days ago - By: uniQure Inc.
uniQure Announces Pricing of Upsized $300 Million Public Offering
21 days ago - By: uniQure Inc.
uniQure Announces Pricing of Upsized $300 Million Public Offering
3 months ago - By: The Motley Fool
uniQure Narrows Loss in Fiscal Q2
22 days ago - By: Stocktwits
- Mentions:
RY
RY.CA
UniQure Stock Hits 5-Year High As Analysts Hail Huntington’s Therapy Data — Retail Spots ‘Diamond In Rough Of Biotech’
22 days ago - By: uniQure Inc.
uniQure Announces $200 Million Proposed Public Offering
22 days ago - By: uniQure Inc.
uniQure Announces $200 Million Proposed Public Offering
23 days ago - By: Stocktwits
- Mentions:
ITOT
XBI
uniQure Stock Rises Pre-Market After Investigational Huntington’s Disease Drug Slows Disease In Trial
23 days ago - By: uniQure Inc.
uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
23 days ago - By: uniQure Inc.
- Mentions:
HTGC
uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
23 days ago - By: uniQure Inc.
uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease
23 days ago - By: uniQure Inc.
uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease
a month ago - By: uniQure Inc.
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
a month ago - By: uniQure Inc.
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
Please enable JavaScript to continue using this application.